Table 3.
Cross-sectional relationship between wasting, stunting, and underweight and malaria parasitemia at each study collection time point
| Azithromycin communities | Placebo communities | ||||
|---|---|---|---|---|---|
| OR (95% CI) | P-value | OR (95% CI) | P-value | P for interaction | |
| Month 0 | |||||
| Wasted* | 0.70 (0.20–1.89) | 0.52 | 1.38 (0.44–3.63) | 0.54 | 0.37 |
| Stunted† | 0.90 (0.47–1.68) | 0.75 | 0.66 (0.27–1.48) | 0.33 | 0.56 |
| Underweight‡ | 0.84 (0.41–1.62) | 0.61 | 1.15 (0.47–2.60) | 0.74 | 0.56 |
| Month 12 | |||||
| Wasted* | 0.76 (0.28–1.90) | 0.57 | 1.17 (0.51–2.52) | 0.69 | 0.49 |
| Stunted† | 1.15 (0.54–2.31) | 0.70 | 0.75 (0.39–1.36) | 0.36 | 0.37 |
| Underweight‡ | 1.35 (0.62–2.79) | 0.43 | 0.94 (0.43–1.92) | 0.86 | 0.49 |
| Month 24 | |||||
| Wasted* | 1.66 (0.24–6.99) | 0.53 | 0.30 (0.02–1.51) | 0.24 | 0.18 |
| Stunted† | 0.78 (0.22–2.27) | 0.68 | 2.40 (1.04–5.40) | 0.04 | 0.12 |
| Underweight‡ | 1.03 (0.23–3.29) | 0.97 | 0.36 (0.06–1.29) | 0.18 | 0.29 |
OR = odds ratio; all models adjusted for the child’s age in months, gender, and study arm with standard errors adjusted for clustering at the community level and an interaction term for malaria parasitemia by community treatment arm.
* Defined as weight-for-height Z-score < −2 SD.
† Defined as height-for-age Z-score < −2 SD.
‡ Defined as weight-for-age Z-score < −2 SD from 2006 WHO guidelines.